Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease

Despite an enormous research effort, most cases of late-onset Alzheimer's disease (LOAD) still remain unexplained and the current biomedical science is still a long way from the ultimate goal of revealing clear risk factors that can help in the diagnosis, prevention and treatment of the disease. Current theories about the development of LOAD hinge on the premise that Alzheimer's arises mainly from heritable causes. Yet, the complex, non-Mendelian disease etiology suggests that an epigenetic component could be involved. Using MALDI-TOF mass spectrometry in post-mortem brain samples and lymphocytes, we have performed an analysis of DNA methylation across 12 potential Alzheimer's susceptibility loci. In the LOAD brain samples we identified a notably age-specific epigenetic drift, supporting a potential role of epigenetic effects in the development of the disease. Additionally, we found that some genes that participate in amyloid-β processing (PSEN1, APOE) and methylation homeostasis (MTHFR, DNMT1) show a significant interindividual epigenetic variability, which may contribute to LOAD predisposition. The APOE gene was found to be of bimodal structure, with a hypomethylated CpG-poor promoter and a fully methylated 3′-CpG-island, that contains the sequences for the ε4-haplotype, which is the only undisputed genetic risk factor for LOAD. Aberrant epigenetic control in this CpG-island may contribute to LOAD pathology. We propose that epigenetic drift is likely to be a substantial mechanism predisposing individuals to LOAD and contributing to the course of disease.

[1]  Sun-Chong Wang,et al.  Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. , 2008, American journal of human genetics.

[2]  D. Geschwind,et al.  A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging , 2008, The Journal of Neuroscience.

[3]  Demao Chen,et al.  Alzheimer's Disease (AD)-Like Pathology in Aged Monkeys after Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD , 2008, The Journal of Neuroscience.

[4]  John N. Hutchinson,et al.  Widespread Monoallelic Expression on Human Autosomes , 2007, Science.

[5]  Rolf Ohlsson,et al.  Widespread Monoallelic Expression , 2007, Science.

[6]  R. Jirtle,et al.  Metastable Epialleles, Imprinting, and the Fetal Origins of Adult Diseases , 2007, Pediatric Research.

[7]  Rebecca F. Halperin,et al.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.

[8]  Michael B. Stadler,et al.  Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome , 2007, Nature Genetics.

[9]  M. Nelson,et al.  Cytosine methylation profiles as a molecular marker in non-small cell lung cancer. , 2006, Cancer research.

[10]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[11]  R. Feil,et al.  Environmental and nutritional effects on the epigenetic regulation of genes. , 2006, Mutation research.

[12]  F. D’Anselmi,et al.  Corrigendum to “S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production” [Mol. Cell. Neurosci. 28 (2005) 195–204] , 2006, Molecular and Cellular Neuroscience.

[13]  S. Bassett,et al.  Further evidence of a maternal parent‐of‐origin effect on chromosome 10 in late‐onset Alzheimer's disease , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[14]  Arturas Petronis,et al.  Epigenetics and twins: three variations on the theme. , 2006, Trends in genetics : TIG.

[15]  Sun-Chong Wang,et al.  Intra- and interindividual epigenetic variation in human germ cells. , 2006, American journal of human genetics.

[16]  J. Sweatt,et al.  Epigenetic mechanisms: a common theme in vertebrate and invertebrate memory formation. , 2006, Cellular and molecular life sciences : CMLS.

[17]  Arturas Petronis,et al.  Complex disease, gender and epigenetics , 2006, Annals of medicine.

[18]  John K Field,et al.  Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  François Fuks,et al.  DNA methylation and histone modifications: teaming up to silence genes. , 2005, Current opinion in genetics & development.

[20]  G. Martin.  Epigenetic drift in aging identical twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Spector,et al.  Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  N. Bresolin,et al.  Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients , 2005, Neurobiology of Aging.

[23]  T. Sørensen,et al.  Twin study of genetic and aging effects on X chromosome inactivation , 2005, European Journal of Human Genetics.

[24]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[25]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[26]  F. D’Anselmi,et al.  S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production , 2005, Molecular and Cellular Neuroscience.

[27]  R. Basha,et al.  The Fetal Basis of Amyloidogenesis: Exposure to Lead and Latent Overexpression of Amyloid Precursor Protein and β-Amyloid in the Aging Brain , 2005, The Journal of Neuroscience.

[28]  M. Owen,et al.  Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. , 2004, Human molecular genetics.

[29]  Gianluigi Forloni,et al.  Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. , 2004, The American journal of clinical nutrition.

[30]  D. Burke,et al.  Age-associated activation of epigenetically repressed genes in the mouse. , 2003, Genetics.

[31]  B. Richardson.  Impact of aging on DNA methylation , 2003, Ageing Research Reviews.

[32]  Simon M Laws,et al.  Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription , 2003, Journal of neurochemistry.

[33]  Satoshi Tanaka,et al.  Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[34]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[35]  Xiongwei Zhu,et al.  Neurons in Alzheimer disease emerge from senescence , 2001, Mechanisms of Ageing and Development.

[36]  M. Owen,et al.  Genetic risk of Alzheimer's disease: advising relatives , 2001, British Journal of Psychiatry.

[37]  C. Broeckhoven,et al.  Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. , 2000, Human molecular genetics.

[38]  H. Tohgi,et al.  Reduction with age in methylcytosine in the promoter region −224∼−101 of the amyloid precursor protein gene in autopsy human cortex , 1999 .

[39]  L. Nee,et al.  Alzheimer’s Disease in 22 Twin Pairs – 13-Year Follow-Up: Hormonal, Infectious and Traumatic Factors , 1999, Dementia and Geriatric Cognitive Disorders.

[40]  C. Gottfries,et al.  Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker , 1998, Dementia and Geriatric Cognitive Disorders.

[41]  P. Bertolucci,et al.  Differential chromosome sensitivity to 5-azacytidine in Alzheimer's disease. , 1998, Gerontology.

[42]  M. Seeman.  Psychopathology in women and men: focus on female hormones. , 1997, The American journal of psychiatry.

[43]  J. Hardy,et al.  Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. , 1997, Human molecular genetics.

[44]  S. Kish,et al.  Brain S‐Adenosylmethionine Levels Are Severely Decreased in Alzheimer's Disease , 1996, Journal of neurochemistry.

[45]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[46]  P. S. St George-Hyslop,et al.  The upstream promoter of the beta-amyloid precursor protein gene (APP) shows differential patterns of methylation in human brain. , 1994, Genomics.

[47]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[48]  B. Toone,et al.  Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[49]  T. Mikkelsen,et al.  DNA cytosine methylation in brain of patients with Alzheimer's disease , 1990, Annals of neurology.

[50]  A. Milici,et al.  Study of the Alzheimer's A4 precursor gene promoter region by genomic sequencing using Taq polymerase. , 1990, Biochemical and biophysical research communications.

[51]  J. Nalbantoglu,et al.  Genetic Factors in Alzheimer's Disease , 1990, Journal of the American Geriatrics Society.

[52]  S. Schneck,et al.  Twins with Alzheimer's disease. , 1981, Archives of neurology.

[53]  Rolf Ohlsson,et al.  Genetics. Widespread monoallelic expression. , 2007, Science.

[54]  J. Sweatt,et al.  Epigenetic mechanisms: a common theme in vertebrate and invertebrate memory formation. , 2006, Cellular and molecular life sciences : CMLS.

[55]  H. Tohgi,et al.  Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. , 1999, Brain research. Molecular brain research.